Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
04/10/2002 Multaq (dronedarone) - Important Safety Information from Sanofi Aventis as approved by the Irish Medicines Board 3rd Party Publications
30/09/2002 Packaging Error : Dilzem XL 240mg Capsules and Dilzem XL 180mg Capsules Warning
31/07/2002 Suspension of the BCG vaccine licence held by Evans Vaccine Ltd UK Recall
21/01/2000 Ziagen (abacavir sulfate) - Important Safety Information from GlaxoWellcome as approved by the Irish Medicines Board 3rd Party Publications